Gestational Diabetes and Cardiovascular Health

Katy J L Bell; Paul P Glasziou; Jenny A Doust

doi:10.1001/jama.2023.23251

Gestational Diabetes and Cardiovascular Health

Katy J L Bell^*, Paul P Glasziou, Jenny A Doust

^*Corresponding author for this work

Institute for Evidence-Based Healthcare

Research output: Contribution to journal › Letter › Research

Abstract

To the Editor
Good clinical decisions should weigh benefits against harms. The recent JAMA Insights article on gestational diabetes mellitus (GDM) focused on the potential benefits of increased detection and treatment of GDM and subsequent promotion of cardiovascular health.1 Unmentioned were the potential detrimental effects of overdiagnosis on patients’ well-being, clinicians’ workload, and costs to health care systems.

Original language	English
Pages (from-to)	167-167
Number of pages	1
Journal	JAMA
Volume	331
Issue number	2
DOIs	https://doi.org/10.1001/jama.2023.23251
Publication status	Published - 9 Jan 2024

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1001/jama.2023.23251

Cite this

@article{f8c3f3b82a0d4bfe956a179a113e90a9,

title = "Gestational Diabetes and Cardiovascular Health",

abstract = "To the EditorGood clinical decisions should weigh benefits against harms. The recent JAMA Insights article on gestational diabetes mellitus (GDM) focused on the potential benefits of increased detection and treatment of GDM and subsequent promotion of cardiovascular health.1 Unmentioned were the potential detrimental effects of overdiagnosis on patients{\textquoteright} well-being, clinicians{\textquoteright} workload, and costs to health care systems.",

author = "Bell, {Katy J L} and Glasziou, {Paul P} and Doust, {Jenny A}",

year = "2024",

month = jan,

day = "9",

doi = "10.1001/jama.2023.23251",

language = "English",

volume = "331",

pages = "167--167",

journal = "JAMA",

issn = "0098-7484",

publisher = "AMER MEDICAL ASSOC",

number = "2",

}

TY - JOUR

T1 - Gestational Diabetes and Cardiovascular Health

AU - Bell, Katy J L

AU - Glasziou, Paul P

AU - Doust, Jenny A

PY - 2024/1/9

Y1 - 2024/1/9

N2 - To the EditorGood clinical decisions should weigh benefits against harms. The recent JAMA Insights article on gestational diabetes mellitus (GDM) focused on the potential benefits of increased detection and treatment of GDM and subsequent promotion of cardiovascular health.1 Unmentioned were the potential detrimental effects of overdiagnosis on patients’ well-being, clinicians’ workload, and costs to health care systems.

AB - To the EditorGood clinical decisions should weigh benefits against harms. The recent JAMA Insights article on gestational diabetes mellitus (GDM) focused on the potential benefits of increased detection and treatment of GDM and subsequent promotion of cardiovascular health.1 Unmentioned were the potential detrimental effects of overdiagnosis on patients’ well-being, clinicians’ workload, and costs to health care systems.

UR - http://www.scopus.com/inward/record.url?scp=85181999219&partnerID=8YFLogxK

U2 - 10.1001/jama.2023.23251

DO - 10.1001/jama.2023.23251

M3 - Letter

C2 - 38193964

SN - 0098-7484

VL - 331

SP - 167

EP - 167

JO - JAMA

JF - JAMA

IS - 2

ER -

Gestational Diabetes and Cardiovascular Health

Abstract

UN SDGs

Access to Document

Other files and links

Fingerprint

Cite this